Home Tags BMRN

Tag: BMRN

Technical Roundup On Two Stocks – Atlassian Corporation Plc (TEAM), BioMarin...

Atlassian Corporation Plc (NASDAQ:TEAM) recently saw its volume around 1.66 million shares and on average it trades 1.26 million shares a day. The opening...

An Eye On Valuation Metrics Of Sangamo Therapeutics, Inc. (SGMO), BioMarin...

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) is expensive when one looks at the company's price to sales ratio of 25.62 and compares it with other companies...

Investors Certainly Aren’t Enthralled With BioMarin Pharmaceutical Inc. (BMRN), Cummins Inc....

Optimism reigned on a brightened-volume day for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) which added $2.04 between open and close. The number of shares traders wanted...

Potential Opportunity To Buy or Exit? – BioMarin Pharmaceutical Inc. (BMRN),...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is simply too expensive to pass with a price-to-sales ratio of 12.1. The competitors from Biotechnology hold an average P/S...

Let’s Take Some Time To Look Back: The PNC Financial...

After a low volume day for The PNC Financial Services Group, Inc. (NYSE:PNC) ), it's easy to find yourself asking what's next for the...

Offering Potential To Outperform Peers? – BioMarin Pharmaceutical Inc. (BMRN), Continental...

Fundamentally, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) looks unattractive. Its stock trades at 12.47 times the company’s sales over the past 12 months. The broad Biotechnology...

Investors Brace For Impact: BioMarin Pharmaceutical Inc. (BMRN), Prospect Capital Corporation...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) recently had a low trading volume day. The volume for the company on 08-Aug-18 was recorded to be 1.33 million...

Currently Overpriced Or Underpriced? – BioMarin Pharmaceutical Inc. (BMRN), Frontier Communications...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) popped in on a high volume green day. Volume on 07-Aug-18 came in at 3.46 million contracts. The daily trading...

Diplomat Pharmacy, Inc. (DPLO) Trades Cheap While BioMarin Pharmaceutical Inc. (BMRN)...

Diplomat Pharmacy, Inc. (NYSE:DPLO) is simply too cheap to pass with a price-to-sales ratio of 0.33. The competitors from Drugs - Generic hold an...

A Roadblock Ahead? – Amicus Therapeutics, Inc. (FOLD), BioMarin Pharmaceutical Inc....

Aug 03 was a weak volume day for Amicus Therapeutics, Inc. (NASDAQ:FOLD), with a downside momentum. The trading capacity for the firm moved to...